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Odorants inhibit as well as excite primary olfactory receptor neurons (ORNs) in many
animal species. Growing evidence suggests that inhibition of mammalian ORNs is
mediated by phosphoinositide (PI) signaling through activation of phosphoinositide
3-kinase (PI3K), and that canonical adenylyl cyclase III signaling and PI3K signaling
interact to provide the basis for ligand-induced selective signaling. As PI3K is known
to act in concert with phospholipase C (PLC) in some cellular systems, the question
arises as to whether they work together to mediate inhibitory transduction in mammalian
ORNs. The present study is designed to test this hypothesis. While we establish that
multiple PLC isoforms are expressed in the transduction zone of rat ORNs, that odorants
can activate PLC in ORNs in situ, and that pharmacological blockade of PLC enhances
the excitatory response to an odorant mixture in some ORNs in conjunction with PI3K
blockade, we find that by itself PLC does not account for an inhibitory response. We
conclude that PLC does not make a measurable independent contribution to odor-
evoked inhibition, and that PI3K is the primary mediator of PI-dependent inhibition in
mammalian ORNs.
Keywords: odor inhibition, olfactory receptor neurons, phosphoinositide signaling, en face in vivo imaging, single
cell PCR
INTRODUCTION
The process of odor detection and identification begins when odorants bind to olfactory
receptors (ORs) expressed in the cilia of primary olfactory receptor neurons (ORNs) in the
olfactory epithelium (OE) to activate signal transduction. Odorants can inhibit as well as excite
ORNs thereby integrating their responses to complex odor mixtures (Ache, 2010; Thomas-
Danguin et al., 2014; Schubert et al., 2015; Corey and Ache, 2016). The canonical excitatory
signaling pathway in mammals begins with odorant-evoked activation of adenylyl cyclase III
(ACIII) through the olfactory G protein Gαolf, resulting in an increase in the second messenger
cAMP. Subsequent opening of cyclic nucleotide-gated (CNG) channels and Ca2+-activated
Cl− channels depolarizes the ORNs, which fire action potentials to transmit the signal to the
olfactory central nervous system (CNS). In contrast, much less is known about the mechanisms
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through which odorants decrease the output of ORNs, a process
referred to as odor-evoked inhibition.
Odor-evoked inhibition at the level of ORN is often
associated with competitive interaction between the cognate
ligand and an antagonist, as was studied in detail with
the rat I7 receptor (Peterlin et al., 2008). However, there
is growing evidence that at least one other type of odor-
evoked inhibition is mediated by phosphoinositide (PI) signaling
through activation of phosphoinositide 3-kinase (PI3K; Spehr
et al., 2002; Ukhanov et al., 2011a,b, 2013) and that activation of
the cyclic nucleotide-based excitatory and PI3K-based inhibitory
signaling pathways in a ligand biased manner provides the basis
for Ligand-induced Selective Signaling (LiSS; e.g., (Kenakin,
2003; Park, 2012; Shukla et al., 2014) in mammalian ORNs.
As phospholipase C (PLC) and PI3K can be activated in
concert in other cellular systems to regulate cell motility and
chemotaxis (Kölsch et al., 2008), question arises as to whether
PLC is also part of the PI pathway mediating inhibitory
transduction.
This possibility gets traction from the finding that in some
mammalian ORNs relief of odor-evoked inhibition appeared
to require pharmacological blockade of both arms of the PI
signaling pathway, i.e., PI3K and PLC, not just PI3K (Spehr
et al., 2002). There is also evidence that odorants can activate
PLC as well as PI3K in olfactory ciliary membranes (Vogl et al.,
2000; Klasen et al., 2010), and isoforms of both enzymes have
been detected at the level of the OE (Bruch et al., 1995; Brunert
et al., 2010; Ukhanov et al., 2010; Szebenyi et al., 2014), in some
cases in the olfactory cilia (Brunert et al., 2010; Ukhanov et al.,
2010). These findings raise the possibility that PLC and PI3K
both contribute to an inhibitory signaling branch of LiSS.
We now establish that multiple PLC isoforms are expressed in
the transduction zone of rat ORNs, odorants can activate PLC in
ORNs in situ, and pharmacological blockade of PLC enhances
the excitatory response to an odor mixture in some ORNs in
conjunction with PI3K blockade. However, we find that PLC
alone does not account for an inhibitory response. We conclude
that PLC by itself does not make a measurable contribution to
odor-evoked inhibition, and that PI3K is the primary mediator
of PI-dependent inhibition in mammalian ORNs.
MATERIALS AND METHODS
Adult female Sprague-Dawley rats were used in experiments.
All procedures were carried out in accordance with
protocols approved by the University of Florida IACUC. All
experiments were performed at room temperature (22–25◦C).
Calcium Imaging of Dissociated ORNs
Experiments were performed as described previously (Ukhanov
et al., 2011b). In brief, olfactory tissue was dissected in ice-cold
modified artificial cerebrospinal fluid (ACSF) saturated with 95%
O2 and 5% CO2 that contained (in mM): 120 NaCl, 25 NaHCO3,
5 KCl, 1.25 Na2HPO4, 1 MgSO4, 1 CaCl2, 10 glucose, 305
mOsm, pH7.4. After enzymatic digestion in papain (1 mg/mL)
supplemented low-Ca (0.6 µM buffered with CaEGTA) ACSF
at 37◦C for 15 min, the tissue was gently washed with normal
oxygenated ACSF and accurately triturated with a large bore
fire polished glass transfer pipette. The resulting suspension was
filtered through a 40 µm cell strainer (Fisher Scientific) and
stored at 4◦C with added TurboDNAse (1:100 dilution, Ambion)
to prevent cell clumping. An aliquot of the suspension was mixed
with 10 µM Fluo-3/AM (AnaSpec) containing 0.04% Pluronic
F127 and placed on a glass coverslip coated with 1 mg/mL
concanavalin A (Sigma-Aldrich) in a recording chamber (RC22,
Warner Instruments). The chamber was transferred to the stage
of an inverted microscope (Axiovert 200, Zeiss) equipped with
a 10× /0.5NA Fluar objective. To increase the sample size, in
each experimental session the field of view was further expanded
using a 0.63× reducer video tube (Diagnostic Instruments)
between the microscope and the camera. Depending on the
quality of the preparation, approximately 300 ORNs sensitive to
IBMX/forskolin stimulation could be analyzed at once. The cells
were illuminated at 500 nm (BP 500/20 nm, Omega Optical,
USA) and the emitted light was collected at 530 nm (BP
530/20 nm, Omega Optical, USA) by a 12-bit cooled CCD
camera (ORCA R2, Hamamatsu, Japan). Both the illumination
system (Lambda DG-4, Sutter Instruments, CA, USA) and image
acquisition were controlled by Imaging Workbench six Software
(INDEC BioSystems).
Each cell was assigned a region of interest (ROI) and changes
in fluorescence intensity within each ROI were analyzed and
expressed as the peak fractional change in fluorescent light
intensity F/F0 where F0 is the baseline fluorescence before
odor application. Responses were detected and measured when
the change in fluorescence intensity exceeded two standard
deviations above the median noise level. For quantitative
comparison, the peak amplitudes of the responses of different
cells were normalized to the saturated responses elicited by
application of a mixture of 100 µM IBMX (a phosphodiesterase
inhibitor) and 10 µM forskolin (a selective agonist of adenylate
cyclases) to robustly activate the cAMP signaling pathway.
Application of IBMX/forskolin was also used to identify
functional ORNs.
En Face Imaging of the OE Ectopically
Expressing PIP2 Probe and GCaMP6f
Calcium Probe
Plasmids encoding the adenoviral backbone genes and the
shuttle vector were provided by Dr.Jeffrey Martens (University
of Florida) and viruses were prepared according to established
protocols (McIntyre et al., 2012). Briefly, for ectopic expression
in native tissue, PLCdelta1-PH:GFP and GCaMP6f were cloned
into the adenoviral vector pAd/V5/dest and virus was propagated
in HEK293A cells. Adenoviral particles were isolated with the
Virapur Adenovirus mini purification Virakit (Virapur, San
Diego, CA, USA) and dialyzed in 2.5% glycerol, 25 mM NaCl
and 20 mM Tris-HCl, pH 8.0 at 4◦C before storage at −80◦C.
Rats were anesthetized with a Ketamine/Xylazine mixture and
10–15 µL of the viral solution was delivered intranasally as a
single injection per nostril. Animals were used for experiments
at 7–14 days post-infection. Entire turbinates and septums were
dissected and kept on ice in a Petri dish filled with oxygenated
Frontiers in Cellular Neuroscience | www.frontiersin.org 2 April 2016 | Volume 10 | Article 97
Ukhanov et al. Role of PLC in Odor Inhibition
ACSF. For imaging a small piece of the OE was mounted in
the perfusion chamber with the apical surface facing up. The
chamber was transferred to the stage of an upright microscope
Axioskop2F equipped with a 40× NA 0.75 water-immersion
objective lens. Experimental solutions were applied directly to the
field of view through a 100 µm diameter needle made of fused
silica and connected to the 9-channel Teflon manifold (Biologic,
France). Each perfusion channel was controlled by electronic
valves (VC-6, Warner Instruments).
To observe translocation of the PIP2 specific probe
PLCdelta1-PH:GFP, individual dendritic knobs were imaged
through an additional 2.5× video magnifying converter (Zeiss).
The same optical configuration and illumination used to
image dissociated cells was utilized for en face imaging of OE
ectopically expressing PLCdelta1-PH:GFP or the calcium sensor
GCaMP6f. Translocation was measured as an increase in global
intra-knob cytoplasmic fluorescence upon application of the
odor and presented as (F-Fo)/Fo ratio. The calcium response
presented as an increase of GCaMP6f fluorescence emanating
from the knob and underlying cell body. A standard eGFP filter
cube BP490 nm/535 nm (Omega, Brattelboro) was used to image
both probes. Acquisition and illumination were controlled as
described above.
High resolution en face imaging of freshly dissected OE was
performed on an inverted confocal microscope Nikon Ti/A1R+
controlled by the NIS Elements 4.20 Software. Images were
processed using ImageJ (NIH1) and assembled in CorelDraw13
(Corel).
Assay of PI3K Activity
A constitutively active form of the catalytic subunit p110gamma
of PI3K fused to amembrane anchormotif CAAX, (PI3Kgamma-
CAAX; provided by Dr.Wyman, University of Fribourg,
Switzerland) was co-expressed with the PIP3 probe Btk-PH:GFP
(provided by Dr.Balla, NIH/NICHD) in HEK293T cells.
PI3K activation results in an accumulation of PIP3 and in
turn recruitment of Btk-PH:GFP to the plasma membrane.
Application of the PI3K inhibitor LY294002 reduces the PIP3
level in the membrane and Btk-PH:GFP translocates to the
cytoplasm. PI3K-dependent changes in fluorescence were
measured using the same optical configuration and illumination
used to image dissociated ORNs and the PIP2 probe.
Drugs, Odorants, and Solution Application
3-isobutyl-1-methylxanthine (IBMX) and 7β-acetoxy-8,13-
epoxy-1α, 6β, 9α-trihydroxylabd-14-en-11-one (forskolin)
were obtained from Sigma-Aldrich. LY294002 (Tocris),
U73122, U73343 and edelfosine (Cayman). Reagents were
dissolved in anhydrous DMSO and the stocks were kept
at −20◦C. Odorants were delivered as aqueous solutions
prepared in freshly oxygenated ACSF. Octanol (OOL) and
citral (CIT) were of the highest purity (Fisher Scientific) and
were prepared as 0.5 M stock solutions in anhydrous DMSO.
A complex odor mixture (Henkel-100, provided by Prof.Hatt,
University of Bochum, Germany) was diluted 1:10 in DMSO
1http://imagej.nih.gov/ij/
FIGURE 1 | Multiple isoforms of phospholipase C (PLC) are expressed
in olfactory receptor neurons (ORNs). (A) Single-cell RT-PCR with primers
specific for PLCbeta3, gamma2 and epsilon1 was performed on individual
odor-responsive rat ORNs. Representative PCRs for two ORNs (ORN1 and
ORN2) are shown. Olfactory marker protein (OMP) expression confirms that
the cells collected were mature canonical ORNs. Total rat OE cDNA (total OE)
was used as a positive control. Both water (negative control) and no RT RNA
samples were tested as negative controls. (B) Wide-field en face
immunofluorescent images of whole mount fixed rat OE. In addition to
PLCepsilon1, gamma2 and beta3, we have detected the presence of the
delta1 isoform in the knobs of ORNs which are visible as a numerous
fluorescent dots. Large bright spots represent the apical tips of microvillar cells
(arrows). No specific labeling was found with antibodies against the beta4,
eta2 and gamma1 isoforms. Scale bars represent 50 µm.
and then mixed to the final reported dilution with ACSF. ACSF
supplemented with 0.1% DMSO, the odorant carrier, served as
the control solution. Odorant stocks were kept at −20◦C and
the final aqueous solutions were prepared on the day of the
experiment.
Data Analysis
All data are expressed as mean ± SEM. All analyses were
performed with pClampfit 10.2 (Molecular Devices), Microsoft
Excel and SigmaPlot 10 (Systat Software, CA, USA) Software.
Frontiers in Cellular Neuroscience | www.frontiersin.org 3 April 2016 | Volume 10 | Article 97
Ukhanov et al. Role of PLC in Odor Inhibition
RT-PCR
Odor-responsive dissociated ORNs identified by calcium
imaging were collected directly into RT-PCR buffer and
immediately frozen. Thawed cells were used for reverse
transcription with an anchored oligo dT primer using a Verso
cDNA kit (Thermo Fisher). To allow analysis of the expression of
a number of genes, the cDNAswere pre-amplified with Primestar
HS DNA polymerase (Takara) using a cocktail of gene-specific
primers and a primer nested within the anchored-dT primer by
incubating at 95◦C for 2 min followed by 15 cycles of 95◦C for
30 s, 50◦C for 30 s 72◦C for 1 min, then 72◦C for 5 min. Samples
were aliquoted and immediately frozen for later analysis. Beta
actin primers were used to test for contamination with genomic
DNA prior to analysis of PLC expression and olfactory marker
protein (OMP) primers were used to confirm that the cells
were canonical ORNs. PCR detection of the PLC isoforms
was performed with gene specific primers (PLCG2f 5′ACTCT
CTTCTCTCTCAGCCTCCG3′, PLCG2r 5′CAACAAATTC
AAGACGACGGTTGTG3′, PLCE1f 5′TCCAAGTGCACGA
TGTCTCTCCAG3′, PLCE1r 5′GACTGGTAGCCCGCTGTG
TCAC3′, PLCB3f 5′CCAGAACCGACAAGTACAGAGCC3′,
PLCB3r 5′TCCCAGCTGCATGACCATTGC3′) and 10 µl of
each reaction was analyzed by agarose gel electrophoresis.
Whole Mount Immunohistochemistry
Standard immunofluorescent staining of cryostat sections of
fixed OE was not of sufficient quality to resolve anti-PLC
labeling. Instead, we used whole mount fixation of the
OE and en face imaging. To further enhance the labeling,
fixed tissue was incubated in 1% SDS/PBS for 15 min at
RT to retrieve antigens (Brown et al., 1996) followed by
biotin/streptavidin amplification. Freshly dissected rat noses
were fixed for 1–2 h on ice in 4% paraformaldehyde in PBS
and then blocked with PBS containing 10% normal horse
serum and 0.3% Triton X-100 for 1 h at RT. After washing
in PBS, the specimens were incubated with Streptavidin/Biotin
blocking solution as per the manufacturer’s instruction (Vector
Laboratories) followed by overnight incubation at 4◦C with
primary antibodies diluted (1:250) in PBS with 0.1% Triton X-
100 and with no added serum. Primary antibodies against the
respective PLC isoforms were from Santa Cruz Biotechnology.
Biotinylated horse anti-rabbit antibody was diluted 1:500 in
1% BSA and incubated with the specimens for 1 h at RT.
After extensive washing in PBS, the specimens were incubated
with Streptavidin-Dylight-488 conjugate (1:200–1:33) in PBS.
For double labeling, mouse antibody against acetylated alpha-
tubulin (1:1000, Sigma Aldrich) was mixed directly with
primary antibody. Secondary anti-mouse Alexa 568 (1:1000)
also was added directly to Streptavidin reaction mix. The
processed specimens were analyzed using an inverted confocal
microscope Leica SP5 (Leica Microsystems). Images were post-
processed using ImageJ (NIH2) and assembled in CorelDraw13
(Corel).
RESULTS
Expression of Multiple Isoforms of PLC at
the Single Cell Level in Rat ORNs
In the founding experiments leading to this line of investigation
(Spehr et al., 2002), a few ORNs responded to an odor mixture
only when PI3K and PLC were blocked together, suggesting
that the enzymes may act in concert as part of an inhibitory
2http://imagej.nih.gov/ij/
FIGURE 2 | Higher resolution confocal en face images of PLC gamma2 (green) visualized in whole mount rat OE (A) and superimposed on the
wide-field DIC image to accentuate localization at the dendritic knobs of ORNs (arrowheads). Apices and cell bodies of neighboring non-sensory
microvillar cells appear brightly labeled (arrows). (B) Acetylated α-tubulin (ac-tubulin; red), a known olfactory ciliary marker protein, was used to counterstain OE
labeled with PLCgamma2 (green). Numerous yellow dots are dendritic knobs expressing both PLCgamma2 and ac-tubulin. Knobs are decorated with ciliary proximal
segments labeled with ac-tubulin. The apical endings of microvillar cells appear as much larger doughnut like structures lacking any surrounding ac-tubulin labeling
(arrows). Scale bars represent 5 µm (A) and 40 µm (B).
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signaling pathway. If PLC contributes to odor-evoked inhibition
in mammalian ORNs, at least one isoform of PLC should be
present in the transduction compartment (the olfactory cilia).
mRNA encoding several isoforms of PLC can be found in
the mouse OE (Szebenyi et al., 2014). We confirmed that
multiple isoforms could be detected in the whole rat OE
by RT-PCR (not shown) and then used calcium imaging to
identify individual ORNs that responded to stimulation with
an odor mixture (Henkel 100, H-100; 1:104 dilution) for a
single cell RT-PCR analysis (Figure 1A). All of the ORNs
tested were positive for expression of OMP, proving they
were a mature canonical ORNs. All analyzed ORNs expressed
both PLCgamma2 and epsilon1, and most of them expressed
PLCbeta3 (Figure 1A). Immunofluorescent staining showed that
PLCbeta3, delta1, gamma2, and eta1 can be localized to the
dendrites of ORNs (Figure 1B). PLCbeta2 was most prominent
in the tips of the microvillar cells as previously described
(Elsaesser et al., 2005), and was not present in the dendrites
of ORNs. Immunofluorescent staining for three other isoforms,
beta4, eta2 and gamma1, was negative and served as a negative
control (Figure 1B). Higher resolution confocal microscopy
supported the localization of PLCgamma2 in the dendritic knobs
at the level of proximal ciliary segment as visualized with
acetylated tubulin labeling (Figure 2). PLC beta3 and delta1
were similarly localized to the dendritic knobs (not shown),
suggesting that several PLC isoforms are present at least at the
level of proximal cilia counterstained with acetylated tubulin
(Figure 2).
Odors Can Activate PLC in ORNs In Situ
If PLC contributes to odor-evoked inhibition in mammalian
ORNs, activation by odorants should be detectable. Earlier,
we found that odors can activate PLC in ciliary enriched
membranes in vitro, as well as in ORNs, but not rapidly
(Klasen et al., 2010). Here we used the same PIP2-specific
translocation probe PLCdelta1-PH:GFP and virally expressed
it in rat OE (Figures 3A,B). H-100 (1:104 dilution) applied
for 5 s evoked a quick increase in fluorescence in some ORN
knobs, directly reflecting translocation of the probe from the
plasma membrane into the cytoplasm of the knobs of 12%
of all tested ORNs (Figure 3C, total 92 knobs used). As
would be expected, the PLCdelta1-PH probe also translocated
to the cytoplasm of sustentacular cells in response to ATP
(100 µM), serving as a positive control for the function of
the probe (Figure 3D). Notably, translocation of PLCdelta1-
PH did not occur in response to activation of the canonical
cyclic AMP signaling pathway following application of an IBMX
(a phosphodiesterase inhibitor)/forskolin (a adenylyl cyclase
activator) mixture (Figure 3C). The kinetics of PLCdelta1-
PH translocation were very similar to those of odor-evoked
excitation as measured with a calcium sensor GCaMP6f that
was virally expressed in a different population of ORNs
(Figures 3E,F). The time to peak was 7.72 ± 1.60 s
for PLCdelta1-PH:GFP compared to 6.28 ± 0.63 s for
GCaMP6f, while recovery back to the baseline occurred in
42.94 ± 5.19 s (PLCdelta1-PH:GFP) and 35.95 ± 1.06 s
(GCaMP6f). We conclude that PLC can be activated in
FIGURE 3 | Odor-evoked activation of PLC detected in the dendritic
knobs of ORNs in situ. (A) En face confocal imaging of live rat OE
expressing the PIP2-specific probe PLCdelta1-PH:GFP induced by adenoviral
vector. Dendritic knobs bearing multiple cilia (arrows) are present in the field of
view along with multiple sustentacular cells (arrowheads). (B) Experiment
performed with epi-fluorescent illumination as shown. Cells expressing
PLCdelta1-PH:GFP are shown in green and superimposed on the DIC image.
Scale bars represent 10 µm. (C) Application for 5 s of the odor mix
Henkel-100 (H-4, 1:104 dilution) but not of IBMX/forskolin (IBMX/Fsk)
consistently evokes a robust increase of fluorescence in the cytoplasm of the
knob denoted with arrow in (B). (D) Application of ATP (100 µM) induced
robust PLC activity and translocation of the PIP2 probe in sustentacular cells
(arrowhead in B). (E) Normalized traces show odor-evoked PIP2 probe
translocation in six different dendritic knobs. (F) A different preparation from a
rat OE expressing the calcium sensor GCaMP6f (insert) used to measure
odor-evoked changes in cytoplasmic Ca2+ in dendritic knobs. Similarly
normalized representative traces of cytoplasmic Ca2+ changes measured in
12 knobs of different GCaMP6f expressing ORNs stimulated by application for
5 s of Henkel-100 (H-4, 1:104 dilution). Insert shows en face confocal image
of an OE with three GCaMP6f expressing ORNs.
ORNs in an odor-dependent manner with kinetics similar to
cAMP-dependent signaling, but through a cAMP-independent
pathway.
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U73122 Specifically Blocks PLC Without
Altering the Activation of PI3K
It is important that any pharmacological probe used to implicate
PLC acts specifically and in particular, does not cause additional
blockade of PI3K. While LY294002 specifically blocks PI3K
at the concentrations tested here (Vlahos et al., 1994), the
specificity and mechanism of action of U73122 have been
disputed (Horowitz et al., 2005; Huang et al., 2013). The
finding that edelfosine, a structurally dissimilar PLC blocker,
also enhances the effect of PI3K in ORNs provides support for
the specificity of U73122, but edelfosine itself can block PI3K
(Ruiter et al., 2003). To substantiate that U73122 selectively
blocks PLC signaling, we transiently expressed a constitutively
active isoform of PI3K, p110gamma-CAAX, (Brock et al., 2003;
Kurig et al., 2009) in HEK293T cells and assessed translocation
of the probe Btk-PH:GFP as a measure of PIP3 production
(Balla and Várnai, 2009). In untreated HEK29T cells expressing
p110gamma-CAAX, Btk-PH:GFP is predominantly localized to
the plasma membrane (Figure 4A). However after incubation
with the PI3K blocker LY294002, the probe translocates to
the cytoplasm (Figure 4B). In contrast, pre-incubation with
the PLC blocker U73122 did not have an effect and did
not alter the effect of adding LY294002 (Figure 4C). These
results indicate that the concentration of U73122 used here acts
specifically on PLC. To ‘‘translate’’ these findings to native
ORNs we compared the action of U73122 with its inactive
analog U73343 in six ORNs. All six cells showed a PLC-
dependent ‘‘add on’’ as described in the following section
when treated with U73122 but not when treated with U73343
(Figure 5), suggesting the drug was also acting specifically in
native ORNs.
Pharmacological Analysis of the Potential
Contribution of PLC to the Response of
ORNs to an Odorant Mixture
We next asked if we could extend the results of the original
study to a larger group of dissociated rat ORNs. The calcium
signal evoked by H-100 (1:105) was measured before and after
pre-treatment with a PI3K-specific blocker (LY294002, 10 µM)
and/or a PLC-specific blocker (U73122, 10 µM), and any change
in the amplitude of the signal was measured. The basic logic
behind these and the subsequent physiological experiments with
native ORNs is that complex odors evoke a net response that
reflects the excitation evoked by one or more components
tempered by any inhibition evoked by another component of
the mixture, and that pharmacologically blocking the inhibition,
if any, results in a net increase in the response magnitude. In
cases of extreme inhibition where there is no initial detectable
excitatory response, this can result in a measurable response after
blockade. For quantitative comparison, the peak amplitude of the
responses of different ORNs were normalized to the saturated
response elicited by application of a mixture of 100 µM IBMX
and 10 µM forskolin (Figure 6). Approximately 15% (n = 17)
of the ORNs that were responsive to an odor mixture (H-100)
increased their response following blockade of PI3K. Five of the
17 ORNs responded significantly to the mixture only when both
FIGURE 4 | U73122 does not inhibit the activation of Phosphoinositide
3-Kinase (PI3K). PI3Kgamma-CAAX, a constitutively active catalytic subunit
of PI3K was heterologously expressed in HEK293T cells. Btk-PH:GFP was
used as a probe to visualize PIP3 generated by the PI3K. (A) The probe is
localized primarily at the plasma membrane (arrows) whereby (B) blocking
PI3K with 10 µM LY294002 (LY294) induces translocation of the probe into
the cytoplasm. Scale bars represent 10 µm. (C) Time course of the
translocation induced by application for 10 s (short bar under the trace) and
30 s (longer bar) of LY294002 (LY294) but not by the PLC inhibitor U73122
(10 µM). Data represent the averaged recordings from 25 cells with error bars
shown in gray. The data is representative of four independent experiments.
enzymes were blocked, as in the original study (Figure 6A).
Combined PI3K and PLC blockade increased the response on
average 4.4-fold from 0.07± 0.03 to 0.29± 0.10. The other twelve
cells increased their response to the odor mixture on blocking
PI3K alone, but half of them (6/12) further increased their
response when PI3K and PLCwere blocked together (Figure 6B).
PI3K blockade increased the response on average 11-fold from
0.04 ± 0.03 to 0.47 ± 0.22, while co-application of the PLC
blocker further increased the response on average 1.7-fold from
0.47 ± 0.22 to 0.79 ± 0.26. This ‘‘add-on’’ effect of blocking
PLC, which was not observed in the original study, could
suggest the two enzymes work in a graded manner depending
on the extent of inhibition evoked by the odor mixture for that
particular ORN.
The other half of the ORNs (6/12) that increased their
response to the odor mixture on blocking PI3K alone, however,
showed no additional effect of blocking PLC (Figure 6C).
In these ORNs, blocking PI3K alone increased the response
by 3.4-fold from 0.10 ± 0.04 to 0.34 ± 0.09. These cells
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FIGURE 5 | U73122 is a specific blocker of PLC activity in rat ORNs. (A) Representative recording from a dissociated ORN that responded to H-100 (H-5,
1:105 dilution) showing that the increased response resulting from PI3K blockade with LY294002 (LY294) is further enhanced by pre-incubation with the active
compound U73122. The inactive analog U73343 had no effect. (B) Responses were normalized to the response activated by a mixture of IBMX and forskolin
(IBMX/Fsk, 100/10 µM each), confirming that these cells are canonical ORNs. A total of 6 cells were used. Asterisks denote significant difference between adjacent
data sets (∗∗p < 0.01).
potentially had near saturated responses following PI3K blockade
and therefore may have been unable to generate a measurable
increase in output with PLC blockade. The critical metric,
however, is whether a particular ORN has more inhibition
to be relieved, not the strength of the response per se. As
a more rigorous assessment, we tested two additional ORNs
that showed no additional effect of blocking PLC with several
concentrations of the PI3K blocker to determine whether there
was an effect of PLC blockade under non-saturating conditions.
In both of the cells tested, there was no effect of blocking
PLC even at the lowest concentration of PI3K blocker tested
when there was clearly more inhibition that could be relieved
(Figure 6E).
In stark contrast to blocking PI3K alone, blocking PLC alone
did not affect the response to the odor mixture in any of the cells
tested, even in those in which blocking PI3K indicated there
was inhibition to be relieved (Figures 6B,D). This was also true
for 29 of a larger group of 35 dissociated ORNs not tested for
their response to blockade of PI3K (Figure 7A). In 6 of the 35
ORNs, however, a significant decrease in the response to the
odor mixture was measured following PLC blockade averaging
3.6 fold from 1–0.28 ± 0.15 (Figures 7B,C). Interestingly, the
incidence of cells showing a decreased response following PLC
blockade (6/35, ca 17%) approximates the average incidence of
PI3K dependency evoked by H-100 (ca 15%). To be sure the
absence of an effect of blocking PLC alone was not imposed
by using dissociated ORNs, we replicated the same experiment
on 38 ORNs imaged in a semi-intact preparation of live OE
virally expressing GCaMP6f and obtained essentially the same
result (Figures 7D–F). Together these results indicate that PLC
signaling is not an obligatory component of PI-based inhibitory
signaling, nor is its activation required in conjunction with
odor-evoked PI3K signaling.
Pharmacological Analysis of the Potential
Contribution of PLC to the Response of
ORNs to a Defined Inhibitory Odorant Pair
Previously, we identified several inhibitory odorant pairs and
showed that the increase in the strength of the response
following PI3K blockade reflects a PI3K-dependent increase in
the agonistic strength of the ‘‘antagonist’’ (Ukhanov et al., 2010,
2011b). Given the possibility that the data obtained with H-100
may be confounded by the complexity of the mixture, we tested
the effect of blocking PI3K and PLC on one such inhibitory
odorant pair, OOL and CIT. We analyzed seven ORNs that
were excited by OOL and inhibited by CIT in a PI3K-dependent
manner. The response of all of these cells to CIT was increased
by blocking PI3K (Figure 8) and further increased following
blockade of PLC with either U73122 (Figure 8A) or edelfosine
(Figure 8B). Since similar data were obtained for both PLC
blockers, the results were pooled for analysis (Figure 8C). PI3K
blockade increased the response to CIT (100 µM) on average
6-fold from 0.05 ± 0.02 to 0.30 ± 0.13 for PI3K blockade
alone and 3-fold from 0.30 ± 0.13 to 0.88 ± 0.18 for combined
PI3K and PLC blockade. This finding argues that the data
obtained with H-100 were not odor-specific nor potentially
confounded by the complexity of the mixture. It also suggests
that the response of any one OR to pharmacological treatment
is consistent; with the caveat that we cannot be certain all seven
cells expressed the same OR despite their common response
profile.
DISCUSSION
We elected to use a pharmacological approach to test
whether PLC is a necessary component of a PI-based
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FIGURE 6 | Blocking PLC activity with U73122 (10 µM) further increases the response evoked by a complex odor mix Henkel-100 (H-5, 1:105 dilution)
and enhanced by pre-treatment with the PI3K inhibitor LY294002 (10 µM, LY294). (A–C) Representative recordings from dissociated rat ORNs clearly show
three types of PLC-blocker induced enhancement. (A) In one set of cells (5/15) blocking PLC and PI3K in combination was necessary to increase the response to
H-100. (B) In another set of cells (6/15) blocking PI3K alone enhanced the response and adding U73122 led to a further increase, and (C) finally in the third set of
cells (6/15) the PLC blocker did not further increase the PI3K-blocker dependent effect. Odor was applied for 5 s at the time indicated with the arrowhead. Horizontal
bars indicate 15 s application of the drugs 10 µM LY294002 and 10 µM U73122. (D) The net effect of blocking PLC activity in ORNs (n = 15) was an increased odor
response after blocking activity of PI3K and PLC together. However, in four cells showing an increased response due to PI3K and PLC blockade, pre-incubation with
U73122 alone did not induce any effect (empty bar). The response amplitude of each cell was normalized to the maximum evoked by IBMX/Forskolin (100/10 µM,
IBMX/Fsk). Asterisks denote a significant difference between data sets (n.s., non-significant; ∗p < 0.05; ∗∗p < 0.01). (E) Representative recording from one of two
cells showing a PI3K-dependent increase in the response to H-100 (H-5, 1:105 dilution). Reducing PI3K blockade by using lower concentrations of LY294022
(LY294), 1 µM and 3 µM, did not reveal a PLC dependent add-on when 10 µM U73122 was co-applied.
inhibitory signaling pathway in mammalian ORNs. While
the question could be addressed by comparing responses
of mice deficient in PLC with those of wild type animals,
multiple PLC isoforms are expressed in ORNs, and even if
the appropriate isoform of PLC was known, this approach
would require statistical comparison of the incidence of
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FIGURE 7 | Blocking PLC alone reveals no increase of the response to a complex odor mix. (A) Dissociated rat ORNs responding to application of
Henkel-100 (H-5, 1:105 dilution) in 29 of 35 cells showed no change when pre-treated with the PLC blocker U73122 (10 µM). (B) However in six of 35 cells blocking
PLC significantly and reversibly reduced the response. (C) Responses were normalized to the amplitude of that evoked by the first application of the odor. Six cells
with responses reduced by the PLC blocker were grouped separately to exemplify the effect (middle bar). (D) The same experiment was replicated using an intact
OE expressing adenovirally induced GCaMP6f. Similar to dissociated cells, blocking PLC either did not evoke any effect (22/38 cells, D) or reversibly reduced the
odor-evoked response (16/38 cells, E). (F) Again cells with responses reduced by the PLC blocker were grouped separately to exemplify the effect (middle bar).
Asterisks denote significant difference between adjacent data sets (∗∗p < 0.01).
inhibitory responses across broad samples of ORNs. Although
the calcium signal manipulated pharmacologically is slow
compared to the actual spike discharge of ORNs, we previously
validated the correlation of these two signal types under
conditions similar to those used here (Ukhanov et al.,
2010).
We confirmed odor-evoked activation of PLC in ORNs
using a fluorescent probe that binds specifically to PIP2 and
translocates in response to its hydrolysis. The incidence of
translocation in infected ORNs (8–13%) correlates roughly
with that of PI3K-based inhibition evoked by the same
odor mixture (H-100, 15%). Translocation did not occur in
response to a mixture of IBMX and forskolin, suggesting
that it is evoked via a cAMP-independent pathway. While
these findings are consistent with PLC activation in concert
with PI3K in the context of odor-evoked inhibition, they are
also compatible with recently described PLC-dependent odor-
evoked excitatory calcium responses (Szebenyi et al., 2014).
Adding to this uncertainty, PLC probe translocation was
measured in the dendritic knob, not in the olfactory cilia
where transduction occurs. Thus, the odor-evoked activation of
PLC we report was not necessarily occurring in the context of
inhibition.
The possibility that odor-evoked activation of PLC is not
related to inhibition is supported by our finding that blocking
PLC alone does not enhance excitation, even in ORNs that
displayed PI3K-dependent inhibition. Indeed, when an effect
of blocking PLC alone was seen, it was in the opposite
direction—it reduced the odor-evoked output (see below for
explanation). Given that blockade of PLC alone is not sufficient
to enhance odor-evoked excitation and that activation of PLC
in concert with activation of PI3K is not an obligatory part
of the pathway, our findings raise the question of whether
the PLC effect is experimentally imposed. Both enzymes utilize
a common substrate, PIP2 (Di Paolo and De Camilli, 2006),
hinting at a logical point of interaction at which blockade of
either enzyme could result in a larger pool of substrate for
the other. This is particularly salient if in olfactory cilia, as in
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FIGURE 8 | Enhancement of the response to a known PI3K-dependent ligand citral (CIT) by both PI3K and PLC blockers. Data were collected from
five dissociated rat ORNs that were strongly excited by 50 µM octanol (OOL; not shown) and were robustly inhibited by co-application of 100 µM CIT (100 CIT).
(A) Pre-incubation of cells with the PLC blocker U73122 (10 µM) significantly increased the PI3K blocker LY294022 (LY294)-dependent response. (B) A similar effect
was observed in two other cells pre-incubated with a structurally distinct PLC blocker edelfosine (25 µM, Edelf). Odorant application is indicated by arrowheads.
Blockers were applied at times indicated by horizontal bars. (C) Responses were normalized to the response activated by a mixture of IBMX and forskolin (IBMX/Fsk,
100/10 µM each). Asterisks denote significant difference between adjacent data sets (∗p < 0.05; ∗∗∗p < 0.001).
other primary cilia (Chávez et al., 2015; Garcia-Gonzalo et al.,
2015), the levels of PIP2 are low and likely a limiting factor.
Blocking PI3K could increase the pool of PIP2 available to PLC,
resulting in a proportionally larger increase in DAG. Exogenous
DAG can inhibit the heterologously-expressed olfactory CNGA2
channel (Crary et al., 2000) and also blocks the response
of dissociated mammalian ORNs to odorants (Ukhanov, not
shown). Increasing the pool of PIP2 available to PLC could
either generate more DAG or increase the rate at which it is
produced enough to see an effect on odor-evoked inhibition.
If this is the case, however, we would expect to observe an
increase in the output of ORNs resulting from PLC blockade
when PI3K is blocked in a graded manner since there was
clearly inhibition to be relieved, as well as an enhancing effect of
blocking PLC alone in at least some ORNs, but neither of these
occurred.
Conversely, blocking PLC could increase the pool of PIP2
available as a substrate for PI3K, resulting in a proportionally
larger increase in PIP3. This explanation is consistent with
our observations that blocking PLC increases the odor-evoked
response only when PI3K is blocked and that the consequence
of blocking PLC alone is a decreased response. Since the ratio
of inhibitory to excitatory odorants in H-100 for any given OR
differs, we assume the level of inhibition, and therefore the
demand on the pool of PIP2, differs across cells so that the
effect of blocking PLC by itself would not necessarily result in
a decrease in the response of every ORN. This is consistent
with our finding that blocking PLC alone failed to reduce
the odor-evoked response in a few cells that displayed PI3K-
dependent inhibition. Thus, there is a reasonable explanation as
to how pharmacological manipulation could impose an apparent
contribution of PLC to inhibitory signaling in mammalian
ORNs, although more targeted experimentation is required for
confirmation.
Our findings are not to suggest that PLC is without functional
significance in ORNs, just that it is not necessary for the
inhibitory pathway investigated here. Indeed, odor-evoked PLC
activity in the transduction zone is required for there to be
a pharmacologically imposed effect on inhibitory signaling.
Odorants have long been known to activate PLC in isolated
ciliary membrane preparations (Vogl et al., 2000), although the
role of PLC in olfactory transduction has been controversial
(Brunet et al., 1996; Belluscio et al., 1998; Wong et al., 2000).
Recently, however, odor-activated PLC has been implicated in
activity-dependent survival and stress mitigation as well as in
releasing calcium from intracellular stores in mammalian ORNs
(Szebenyi et al., 2014; Kim et al., 2015a). Interestingly, PI3K has
also been implicated in activity-dependent survival (Kim et al.,
2015b). A signaling pathway activated by the OR and involved
in activation, in this case inhibition of excitation, presumably
would have particular salience in promoting activity-dependent
survival.
In light of the present findings, we have simplified our
working model of LiSS in mammalian ORNs to emphasize PI3K
as the primary mediator of PI-based inhibitory signaling. In
this model, activation of an ORN by an opponent odorant pair
such as OOL/CIT studied herein would involve the inhibitory
odorant (CIT) activating a PI3K-dependent pathway that
opposes ACIII signaling by the excitatory odorant (OOL)
in a ligand selective manner. Exogeneous PIP3, the primary
product of PI3K signaling in vivo, suppresses activation
of the olfactory CNG channel by cAMP (Zhainazarov
et al., 2004; Brady et al., 2006), indicating a downstream
mechanism through which PI3K activation can mediate
inhibition. Screening a panel of odorants for PI3K-dependent
inhibition found that many, including some occurring
together naturally in an odor object, can activate the pathway
(Ukhanov et al., 2013), suggesting that this working model
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of olfactory LiSS is likely applicable to many mammalian
ORNs.
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